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"In treating cancer,
we’re always in a race
between us and the
cancer. We want to
be ahead in the
game.”
- Wahid Hanna, MD
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Dear Alumni
and Friends,
From introducing to this region the concept of
a multidisciplinary team to bringing advanced
research, new procedures and expanded cancer
screenings, The University of Tennessee Medical
Center Cancer Institute has long been a leader
in the diagnosis, treatment, and prevention
of cancer.
The dedicated, board certified physicians and
staff of the Cancer Institute have long recognized
that the community benefits most from never
having to receive their care. Our team has
created screening and education programs
specifically aimed at minimizing the chances
that our community members will develop
cancer, or diagnosing it in the earliest stage
possible for the best chance of survival.

Upon screening, diagnosis, and treatment,
our focus remains a commitment to education,
research, and better patient outcomes. Our
clinical trials program delivers information
the entire world can utilize in the treatment
Copyright ©2009
of oncology. Several new procedures introduced
The University of Tennessee
to the region by the medical center offer patients
Medical Center
more treatment options than ever before.
All Rights Reserved.
10 | FrontiersThese clinical processes, coupled with a team
EEO/TITLE VI/TITLE IX
that understands the importance of helping
Sec. 504/ADA
patients and their families cope with and prepare
Send Correspondence to:
for each step of their care, results in personalized
Frontiers
care in a compassionate environment. I hope
1520 Cherokee Trail, Suite 300
you’ll find the information in this edition of
Knoxville, Tennessee 37920-2205
Frontiers beneficial.
Telephone: 865-305-6845
Fax: 865-305-6959
E-mail: frontiers@utmck.edu
Web: www.utmedicalcenter.org
or http://gsm.utmck.edu

Sincerely,

This edition of Frontiers shows why the
University of Tennessee Medical Center is
widely recognized for its patient care, research,
and education in cancer. Our well established
clinical care has been enhanced with the addition
of highly skilled faculty. They bring advancing
technologies and treatment to our patients
from all walks of life. In addition, their research
efforts in the laboratory and in clinical trials
shape our uniqueness as an academic medical
center. Through collaboration with researchers
across the country and around the world they are
able to make discoveries that help increase our
nation’s cancer survival rates.
Equally important, this edition showcases our
staff who provide services ranging from cancer
prevention to palliative care. We are proud
to say that many of them go well beyond the
walls of the medical center to help those in the
community. Their attitude and behavior reflect
their passion for care.
As you know, we have a strong team approach to
cancer as evidenced in this edition with faculty
and staff from many departments playing a role
in our patients’ lives. This specialized approach
in patient care, education, and research illustrates
the ability of our academic medical center in
addressing the issues of cancer.

Compassionate, Comprehensive & Coordinated Care
Setting a Standard for Excellence
As the largest provider of cancer care in East Tennessee, the
University of Tennessee Medical Center Cancer Institute diagnoses
and treats more than 1,800 new cases of cancer each year – a
figure based on data from the institute’s renowned tumor registry.
The cancer program, continuously accredited since 1980, couples
the most advanced equipment and procedures with a team of
caring, dedicated specialists to provide exceptional services
and support in one location throughout each stage of care from
diagnosis through treatment. Last year the staff’s day-to-day
commitment to delivering high quality and state-of-the-art services
was honored when the Cancer Institute received one of only 92
outstanding-achievement awards in the United States, the first and
only facility in the region.
The Cancer Institute’s board-certified specialists treat patients
affected by cancer at all major disease sites. They’re supported by a
comprehensive team and services that include clinical trials, clergy,
complementary therapies and relaxation treatments, dietitians, an
education coordinator, geneticists, a mastectomy boutique, nurses,

occupational therapists, outreach services, pharmacists, patient
navigators, physical therapists, self-help and support groups,
social workers, technicians, volunteers, and multi-disciplinary
conferences where cancer specialists collaborate to develop
individualized patient care plans. Out of that complex diversity of
people and services working together a common thread is woven:
the delivery of excellent care, cutting-edge research, and education
for our patients and fellow providers. All this is accomplished
by means of advanced equipment and technologies along with
personalized care delivered in a warm environment.
We’ve come so far, yet we have so far to go.
At the University of Tennessee Medical Center Cancer Institute,
our dedication to those we serve in the community remains
incomparable. Through leadership and commitment, we will
continue to offer the highest quality patient care along with
the most advanced technologies and treatments, not otherwise
available in the region.
We’ll continue to search for keys that can unlock the unsolved
mysteries of cancer. Through collaborative research efforts at
the basic-science, translational, and clinical levels, we’ll advance
disease prevention, reduce the risk of cancer, make earlier
diagnoses, develop treatments with less toxicity and fewer side
effects, and improve the quality and duration of life for our
patients. Resources that include human and intellectual capital are
vital to our success, past, present, and future.

Sincerely,

James J. Neutens, PhD
Dean
UT Graduate School of Medicine

Joseph R. Landsman, Jr.
President and Chief Executive Officer
University Health System, Inc.

For the people of East Tennessee, there’s the reassurance of
knowing that if the need arises they’ll receive top-quality cancer
care and compassionate support, in one location, from the experts
at the University of Tennessee Medical Center Cancer Institute.
John L. Bell, MD
John L. Bell, MD, director of the
Cancer Institute and professor of surgery
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With Advanced Technologies and
Treatments, Patients Have More Options
When it comes to the treatment and management
of cancer, new options continue to emerge in the
fight against the disease and its effects. Researchers

Cancer Specialists – Board
Certification Matters

estimate that approximately 12 million Americans alive today are cancer
survivors. The overall survival rate for cancer patients rose from 50% in
the period between 1975 and 1977 to 66% in the period between 1996
and 2004. How was that possible? Thanks to advanced treatments and
technologies, people diagnosed with cancer have been given access to more
effective treatment options, and survival rates have increased accordingly.

At the University of Tennessee Medical Center Cancer
Institute, you’ll find a team of physicians dedicated
to providing excellent care for cancer patients. It’s
a commitment that began long before they started
working within the medical center’s walls. The Cancer
Institute physicians are board-certified specialists in
medical oncology, surgical oncology, urology, radiation
oncology, gynecologic oncology, oral and maxillofacial
surgery, and other disciplines.

As an academic medical center, the University of Tennessee Medical Center
Cancer Institute recruits board-certified and fellowship-trained cancer
specialists who continuously explore innovative technologies and bring these
to the people of the East Tennessee region. Treating almost 1,800 new cancer
patients each year, the Cancer Institute physicians are committed to working
together as a multidisciplinary team to evaluate and determine the best
treatment options for each individual patient.
Many new methods of treating cancer are focused on delivering
treatment directly to a tumor site, rather than subjecting the
patient’s entire body to potentialy toxic treatment. These cuttingedge approaches are proving efficacious in giving patients a
better quality of life and producing improved outcomes.
As new treatments emerge, the University of Tennessee Medical
Center strives to make them available to all patients in the area.
At times, it is the first medical facility in the state to perform
such treatments. One of those treatments is microwave
ablation, a technique new in the U.S. that uses probe-directed
microwave energy to ablate, or evaporate tumors.

New techniques like microwave
ablation deliver treatment
directly to a tumor site.

"In surgery, this technique
offers the advantages of killing
tumors situated close to the
blood vessels and ablating
larger tumors."
–Keith D. Gray, MD

4 | Frontiers

James M. Lewis, MD, surgical oncologist, brought isolated
limb infusion to the East Tennessee Region.

This year Keith D. Gray, MD, a surgical oncologist fellowshiptrained at MD Anderson and chief, Division of Sugical
Oncology, performed open hepatic (liver) microwave ablation,
and J. Mark McKinney, MD, an interventional radiologist
and chair, Department of Radiology, performed percutaneous
hepatic microwave ablation. The two physicians were the
first in Tennessee to employ this new technique. Microwave
ablation is currently used for treating tumors in solid organs,
including the kidney and liver. It uses targeted microwave
energy to agitate water molecules in cells, creating high
frictional heat – up to 150 degrees Celsius – that kills the cells
in a tumor. “In surgery,” says Gray, “this technique offers the
advantages of killing tumors situated close to the major blood
vessels and ablating larger tumors.”
Early this year James M. Lewis, MD, an assistant professor of
surgery in the medical center’s Division of Surgical Oncology,
began offering a cutting-edge treatment called isolated limb
infusion. This is a technique used to treat tumors in the legs
or arms of patients with recurrent melanoma or sarcoma.
Using the procedure, Lewis can save a limb from amputation
by restricting blood flow to the limb and then treating it with
high doses of chemotherapy. The benefit of this treatment

What does it mean to be a board-certified physician?
Board certification by the American Board of Medical
Specialties has long been considered the gold standard
in physician credentialing. To become board-certified
in a subspecialty field, candidates must complete one
to three years of additional training in an accredited
fellowship program after three to seven years of
residency, and must pass written practical exams and
sometimes oral exams as well. After that, the Cancer
Institute physicians maintain their certification by
participating in an ongoing process that requires them
to get accredited education and specialty training and
to pass exams that demonstrate their competency. This
continuing education keeps them current on the latest
advances in medical science and technology in their
specialties. Recognizing the high level of training that
certification entails, many patients and the medical
community now inquire more frequently about
physicians’ board-certification status.
As an academic medical facility, the University of
Tennessee Medical Center is founded on education,
research, and discovery – an emphasis that enables
our healthcare professionals to provide the very latest
technologies and treatments to cancer patients. Our
cancer specialists voluntarily undergo the intensive
process of maintaining their board certification,
resulting in the delivery of the highest quality
patient care.
Fall 2009 | 5
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that the chemotherapy is delivered directly to the tumor
site and the rest of the patient’s body isn’t exposed to the
side effects of chemotherapy. “We’re able to circulate the
chemotherapy through that limb without it going into
the whole body,” Lewis says. The medical center is the
only site in Tennessee and one of only five facilities
nationwide that offer this procedure to cancer patients.
Surgical techniques continue to improve, becoming less
invasive and requiring less recovery time for patients.
Robotic surgery performed on the da Vinci Surgical
System at the medical center provides benefits such as
faster recovery, less blood loss, and briefer hospital stays.
This type of surgery, used to treat many different cancers
including prostate, bladder, and gynecologic cancers, is
performed by surgeons who are trained and credentialed
in the use of the high-tech system. Paul Hatcher, MD,
performs robotic surgery for prostate cancer patients and
notes its benefits to them. “Robotic surgery has permitted
me to treat patients knowing they’ll generally have a faster
recovery with less blood loss,” he says.
The da Vinci Surgical System is used for many surgical procedures
including prostate, bladder, and gynecologic cancers.

Along with chemotherapy and surgery, radiation therapy
is one of the three major modalities used in the treatment
of cancer. The Radiation Oncology Division at the Cancer
Institute offers the full array of state-of-the-art radiation
therapy cancer treatments. As radiation techniques
expand to include such therapies as brachytherapy and
CyberKnife radiosurgery, new methods of treatment are
being developed that more precisely target and kill cancer
cells while minimizing the harmful side effects of radiation
to normal tissues.
High-Dose-Rate (HDR) brachytherapy delivers a highly
concentrated dose of radiation for a short period of time
through catheters placed near or in a tumor. This allows
a high dose to be used while sparing the surrounding
healthy tissue. The radiation dose depends on the
tumor’s size, location, and sensitivity to radiation. HDR
applications continue to multiply; they are currently used
in treating breast, prostate, lung, and gynecologic cancer.
The CyberKnife radiosurgery system, the only one of its
kind in Knoxville, is a treatment option that precisely
delivers high-dose beams of external radiation to tumors
anywhere in the body. Patients receive one to five radiation
treatments on the CyberKnife, and the treatments, given on
an outpatient basis, are painless. A patient can be treated
with CyberKnife in the morning and resume normal
activities that afternoon.
As cancer treatments advance, partnerships are evolving
to expand research and the possibilities for better patient
outcomes. Eric Carlson, DMD, MD, chairman of the
medical center’s Department of Oral and Maxillofacial
Surgery, and David Gerard, PhD, a professor of oral
and maxillofacial surgery and director of the electron
microscopy at the UT Graduate School of Medicine, are
working together to identify tumor characteristics that can
help in predicting the best treatments for patients. In oral,
head, and neck cancers, being able to foresee a tumor’s
behavior and future development can enable physicians to
treat it according to its predicted progression. This project
exemplifies translational research which takes basic science
research discoveries quickly into medical practice. The
physicians are looking to harvest DNA from cancer tissue,

Outstanding Achievement Award
Daniel Green, MD, radiation oncologist, monitors
a HDR prostate cancer treatment.

then generate a profile to determine the future
progression of the disease. “Translational research
provides the opportunity for cancer clinicians and
basic science researchers to enter into a meaningful
interaction that benefits patient outcomes,” Carlson
says, “This concept supports the vision statement of
the University of Tennessee Medical Center Cancer
Institute to overcome the challenge of cancer
through treatment, research, and education in
partnership with those we serve.”
As an academic medical center with boardcertified physicians in all specialties, the University
of Tennessee Medical Center offers enhanced
patient care and brings the latest treatments and
technologies to the people of East Tennessee and
beyond. The medical center’s cancer patients
receive treatment from dedicated, highly skilled
specialists working as a team, and they receive
the benefits of this collective effort in the form of
individualized treatment plans and delivery of
the most advanced care. Though the mystery of
cancer has not yet been solved, the work continues,
focusing on research and discovery, improvements
in treatment, and the best possible quality of life
for patients.
Melissa Winchenbach
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The Commission on Cancer (CoC) of the American College
of Surgeons recently granted its Outstanding Achievement
Award to the University of Tennessee Medical Center, Cancer
Institute. One of 92 facilities nationwide that received the
award out of 478 surveyed in 2008, the medical center is
the first and only facility in East Tennessee to win the honor,
which was established by the CoC in 2004 to recognize
cancer programs that strive for excellence in providing
quality care to their patients.
The University of Tennessee Medical Center Cancer Institute
became a recipient of the award after a physician surveyor
conducted an on-site evaluation in May 2008. The medical
center demonstrated compliance with all 36 cancer program
standards and achieved a “commendation” level, meaning
the highest level of compliance in seven designated standards
that represent the full scope of cancer program activity:
cancer-committee leadership, cancer data management,
clinical services, research, community outreach, and quality
improvement.
The American College of Surgeons Commission on Cancer,
established in 1922, is a consortium of professional
organizations dedicated to improving survival rates and
quality of life for cancer patients through standard-setting,
prevention, research, education, and the monitoring of
comprehensive quality care. Approval by the CoC is given
only to facilities that have made a voluntary commitment
to providing the highest level of quality cancer care and
that undergo a rigorous evaluation process, including an
on-site review of their performance every three years. The
Cancer Institute at the medical center has been continuously
accredited since 1980.
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The Importance of
Colorectal Cancer Screening
It’s the third leading cause of
cancer-related death in the
United States. It’s the third most

it’s detected during its earliest and most
curable stages.

commonly diagnosed cancer in both
men and women. And it’s one of the
most preventable forms of cancer. It’s
colorectal cancer, and it is diagnosed in
approximately 150,000 Americans each
year. But this disease – cancer of the colon
or rectum – has a 90% survival rate if

The problem is that few people follow
colorectal screening guidelines. “Only four
in 10 people in the recommended age
range get screened, which would catch
colorectal cancer at an early stage,” says
Dr. Ramanujan Samavedy, the region’s first
and only fellowship-trained endoscopic
ultrasound gastroenterologist, who joined
the University of Tennessee Medical
Center. “Every year 50,000 people die
of colon cancer, and most of those are
preventable by early screening.”

Deaths from colorectal cancer have
declined over the past 20 years, an
improvement that’s attributable to
increased public awareness, colorectal
screening, and early detection. Regular
screening can reduce the incidence of the
disease – and the resulting mortality – by
identifying and removing precancerous
polyps. Colorectal-cancer screenings
should begin at about age 50 for both men
and women. Screenings should include
an annual fecal occult blood test and a
fiber-optic sigmoidoscopy every five years
or a colonoscopy every 10 years, based on
test results and doctor recommendations.
“If a family member has had colon polyps
or colon cancer, then the screenings need
to start earlier – usually at an age 10 years
younger than the family member was
when diagnosed,” Samavedy says.
According to the American Cancer Society,
about one in 19 people will develop
colorectal cancer over their lifetime with
men at slightly higher risk. Some of the
risk factors for the disease, in addition to
age and family history, are heavy alcohol
consumption, obesity, physical inactivity,
and smoking.

Meet Dr. R amanujan Samavedy
First fellowship-trained endoscopic ultrasound gastroenterologist
in the East Tennessee region
Practice: University Gastroenterology
Board certification: American Board of Internal
Medicine, Gastroenterology
Medical school: Jawaharlal Institute of Medical
Education and Research, Dhanvantari Nagar,
Punducherry, India
Residency: Indiana University Medical Center
Fellowships: University of Wisconsin and Indiana
University
Clinical interests: Pancreatic and biliary 		
disease and general gastroenterology
Quote: “I believe in listening to my patients and
individualizing care for their specific 		
digestive disorders.”
8 | Frontiers

Reason for becoming a doctor: The son of a
family physician, he was inspired to become a
physician in order to help people
Hobbies: Tennis, hiking, camping

Screening Options for
Colorectal Cancer
Unfortunately, colorectal cancer usually is at an advanced
stage by the time signs or symptoms appear. For that reason,
screening is critically important. The common symptoms of
colorectal cancer include:
• A change in bowel habits
• Diarrhea, constipation, or a feeling that the
		 bowel isn’t completely emptying
• Blood in the stool
• Stools that are more narrow than usual
• Abdominal discomfort (frequent gas pains,
		 bloating, cramps, or feelings of fullness)
• Unexplained weight loss

Fecal occult blood test: This procedure is used
to find small amounts of hidden blood in the stool. Someone
who’s having the test will receive a kit and instructions
explaining how to take samples at home. The kit is then
sent to a lab for testing. If the result is positive, there will be
further tests to pinpoint the exact cause of the bleeding. A
negative test result doesn’t necessarily show that cancer is
absent; a sigmoidoscopy or colonoscopy is needed as well, to
complete the full screening process.
Flexible sigmoidoscopy: A sigmoidoscope is a
slender, lighted tube about the thickness of a finger. In this
test, the tube is inserted through the rectum into the lower
part of the colon so that the doctor can look for cancer or
polyps inside the rectum and part of the colon. (Because the
tube is only about 2 feet long, the doctor can see about half
of the colon’s length.)

• Constant tiredness

Colonoscopy: A longer version of the sigmoidoscope,

• Nausea and vomiting

a colonoscope allows the doctor to examine the entire colon.
If a polyp is found, the doctor may remove it. If anything
else looks abnormal, a biopsy may be
performed and the tissue tested further for
cancer cells.

In many cases these symptoms signal other conditions, so it’s
important to see your doctor to identify potential problems that
can be diagnosed and treated early. “Colon cancer has a good
outcome if there’s an early diagnosis,” Samavedy says. “When
received regularly, screening can prevent many deaths related
to colorectal cancer.”
The University of Tennessee Medical Center makes use of the
most advanced technologies for the diagnosis and treatment of
colorectal cancer. Once an abnormality is found or colorectal
cancer is diagnosed, the patient may have additional tests
such as endoscopic ultrasound (EUS). The most accurate
technique for determining the stage of some forms of colon,
rectal, pancreatic, stomach, and esophageal cancers, EUS also
is used to biopsy lymph nodes in the chest and abdomen and
to evaluate benign tumors in the gastrointestinal tract. “This is
a new and challenging technology that has new applications
every day,” Samavedy says. “I became fellowship-trained
because endoscopic ultrasound has a valuable role in staging
cancers, in that it helps patients be identified for proper
treatment without having to undergo surgery for staging.” The
role of EUS continues to expand and now includes treatment
of cysts in the pancreas and abdomen and occasional use in
marking tumors for radiation.
The most effective treatment for colorectal cancer is surgery,
which may be used in combination with chemotherapy or
radiotherapy. “Most patients diagnosed at an early stage can

A digital rectal exam should be done
at the same time as sigmoidoscopy or
colonoscopy.

be successfully treated and can return to their normal
routine within a few months,” says Dr. Keith Gray, a surgical
oncologist. Along with other medical center physicians, Dr.
Gray uses the most advanced surgical techniques to treat
colorectal and other GI-related cancers.
Colorectal cancer risks can be reduced if you make wise
dietary and lifestyle decisions and follow recommended
screening guidelines. Or if it develops, it can be cured
with timely screening, advanced technology, and effective
treatment options. Give yourself the best chance to beat
colorectal cancer by following the screening guidelines – and
if you’re diagnosed with the disease, seek expert care from
the physicians at the University of Tennessee Medical Center.
Wendi Hope Hager
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Teresa Palmer, APN, consoles family members on
symptom management options for loved ones.

Continuing Quality of Life
University Palliative Care (UPC) began offering consultative
services to physicians and hospitalized patients at the University
of Tennessee Medical Center in 2008. Palliative care is a medical
specialty focused on the relief of pain, symptoms, and emotional
suffering related to a serious illness, with the goal of improving
the quality of life for patients and their families. The UPC team
is led by John D. Cowan, MD, and advanced practice nurse
Teresa Palmer, APN, both board-certified and experienced in
palliative care. The Center to Advance Palliative Care reports
that approximately 30% of hospitals around the U.S. have
palliative care programs. The medical center’s is one of only a
few in the region.
Historically, this type of care has been associated with “end-oflife care.” But today palliative care is appropriate at any point
during a serious illness and can be delivered along with curative
treatment. With an aging population that’s living longer with
chronic disease, pain and symptom management is critical.
Palliative care programs meet this need but also foster enhanced
patient-physician communication and decision-making. Patients
and caregivers are often faced with difficult choices, and the UPC
staff provides information and support to help them make the
best decisions that are in line with the patients’ goals and desires.
The scope of palliative care includes:
•

Pain and symptom management

•

Assistance with difficult and complex choices

•
		

Coordination of care across multiple physicians
and care settings

•
		

Emotional and spiritual support for the patient
and family

•

Help in navigating the healthcare system

•

Advance care planning

The UPC team of palliative care physicians and advanced
practice nurses has specialized skills and a deep interest in
serving patients with complex, extensive medical and social
needs. UPC works in close collaboration with physicians and
other healthcare providers to improve patients’ quality of life
while involving the families and caregivers. “Palliative care is
here at the University of Tennessee Medical Center to help
support physicians and other providers in the care of patients
with serious and potentially life-threatening illness,” says Cowan.
A patient’s physician is the best person to know if the patient
might benefit from a UPC consultation. UPC is asked to provide
consultations to patients throughout the hospital, with many
different diagnoses. “While the majority of our patients have
cancer,” Palmer says, “we see a variety of people dealing with
life-limiting illnesses such as trauma injuries and cardiac, renal,
and pulmonary disease, as well as neurological disorders and
dementia. Each patient is different in how they respond to
treatment and their goals for treatment are often unique, so
everyone has a customized plan of care.”
During the spring and summer of 2008, the UPC team spent
many hours educating staff, patients, and families about the
services and benefits provided by palliative care. More than
350 new-patient consultations were conducted by the service
during the first year, and volumes continue to grow monthly.
In July 2009, the UPC team made the transition from a solely
consultative service to a full medical program that manages
patient pain and symptoms and offers 24/7 call coverage. Besides
Cowan and Palmer, the team includes Ronald Lands, MD; Vicki
Cannington, APN; and Betsy Xiques, APN. UPC collaborates
closely with the Pastoral Care program, which provides spiritual
support for patients and families. Anne Sprouse is the primary
chaplain working with the palliative care service.
Palliative care is emerging as a medical specialty critical to
the effective delivery of healthcare to millions of seriously ill
Americans. It can offer patients with chronic and life-limiting
illness the best possible quality of life.
Melissa Winchenbach
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The Palliative Care team: John D. Cowan, MD; Teresa Palmer,
APN; Vicki Cannington, APN; Anne Sprouse, chaplain;
Ronald Lands, MD. (not pictured, Betsy Xiques, APN)
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Prevent & Survive
You Can

Cancer

Cancer Prevention and Early Detection
Did you know that cancers caused by smoking, heavy
alcohol use, and sun exposure could be entirely prevented?

regular screenings, many cancers can be prevented or detected
early and successfully treated.

Did you also know that it’s estimated that approximately
one-third of the cancer deaths expected to occur this year
can be attributed to obesity, poor nutrition, and lack of
physical exercise, and that those deaths could be
prevented too?

Cancers of the cervix, colon, and rectum are preventable when
precancerous tissue is detected and removed before it becomes
malignant. Similarly, detection of breast, colon, rectal, cervical,
prostate, oral, and skin cancers in their early stages has greatly
reduced mortality and increased the five-year survival rate for
these cancers to 85% or better.

According to the Centers for Disease Control and Prevention,
cancer is the second leading cause of death in the United States.
With an estimated 562,340 deaths from cancer expected this
year, at least half of all new cancer cases can be prevented or
detected at an early stage by timely screenings.
Everyone is at risk of developing cancer, and the risk increases
with age. This year in Tennessee, approximately 32,570 new
cases of cancer will be diagnosed. Reducing a person’s risk
of cancer isn’t too difficult. With simple lifestyle changes and

Steps for Preventing or Reducing the Risk of Cancer
Cancer symptoms don’t usually appear until the disease is at
an advanced stage. But if screening takes place regularly, before
there are symptoms, cancers such as those of the colon and
skin can be prevented or detected at early stages, when they
are most treatable. You can prevent or survive cancer by
maintaining a healthy lifestyle and having regular screenings
that will detect cancer early. Know when and how often
you need to be screened.

American Cancer Society Guidelines
for the Early Detection of Cancer
Breast Cancer
Breast self-exams should be performed by women starting in their
twenties. Clinical breast exams should be a part of periodic health exams
and should take place about every three years for women in their twenties
and thirties and every year for women 40 and older. Mammograms should
be performed yearly, starting at age 40.

Cervical Cancer

Photo caption here.

All women should begin screenings for cervical cancer about three years
after they start having vaginal intercourse, but no later than 21 years old.
Screening should be done every year with the regular Pap test or every two
years using the newer liquid-based Pap test.
Women 30 years old who have had three normal Pap test results in a row
may be screened every two to three years. Women age 70 or older who
have had no abnormal Pap test results in the last 10 years may choose to
stop cervical-cancer screening. Women of any age who have risk factors
for cervical cancer should continue to be screened.

Patient receiving an annual mammogram.

Colon and Rectal Cancer
Beginning at age 50, both men and women at average risk of developing
colorectal cancer should have one of the following screening tests:

Stephen S. Miller, MD, oncologist,
explains a screening test to a patient.

- A flexible sigmoidoscopy every five years
- A colonoscopy every 10 years
- A fecal occult blood test every year

Rhonda McAnally explains screening
results to a participant in the
community health screening.

Prostate Cancer
The American Cancer Society does not support routine testing
for prostate cancer at this time. The society does recommend that
healthcare professionals talk to men about the potential benefits and
limitations of early-detection testing for prostate cancer before any
screening begins. This discussion should include an offer of testing with
the prostate-specific antigen (PSA) blood test and a digital rectal exam
yearly, beginning at age 50, for men who are at average risk for prostate
cancer and have at least a 10-year life expectancy.
Susan Wyatt

Sources: Cancer Facts & Figures 2008, American Cancer Society; Cancer Prevention & Early Detection Facts & Figures 2009,
American Cancer Society; Estimated New Cancer Cases for Selected Cancer Sites by State, US, 2009*, American Cancer Society.
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Home Care

Supporting Patients
		 With Cancer
The Cancer Institute Offers Support
Services for Patients a nd Families
At the University of Tennessee Medical Center Cancer Institute, we’ve been caring for cancer patients since
our doors first opened. In carrying out this work, we have dedicated ourselves to providing each patient with
compassionate, comprehensive, and coordinated care delivered with a multidisciplinary, innovative approach.
But a diagnosis of cancer is unavoidably frightening, and its emotional effects can be as hard to deal with as
the physical ones. At the medical center, we offer not just the most advanced medical care but are committed
to meeting our patients’ full range of needs – physical, social, psychological, and spiritual.
The support team at the Cancer Institute includes physicians, nurses, chaplains, cancer survivors, social
workers, dietitians, trained breast-prosthetic consultants, and volunteers. Each of them works closely with
patients and their families to ensure that individual needs are met.

Befitting You Mastectomy Boutique
Located in the Cancer Institute, the Befitting You Mastectomy Boutique is specially designed
for women who have had breast cancer surgery or are undergoing chemotherapy or radiation
therapy. It’s staffed by certified breast-prosthetic consultants who meet one-on-one with
customers in a private setting to find the products or garments that are the right fit for them.

Chaplains
The Pastoral Care department provides spiritual help to patients
and families of any or no religious affiliation. Its chaplains interact
directly with patients and families, ministering to their emotional
and spiritual needs. Our goal is to treat the whole person and foster
hope and faith in sometimes complex and trying circumstances, like
those associated with a cancer diagnosis.

Dietary Support
Good nutrition is an important concern for many cancer patients. Our dietitians are available
to consult with patients on how to:
•  Get proper nourishment and maintain weight
•  Continue eating throughout cancer treatments
•  Select dietary supplements (when appropriate)
•  Eat the right foods after cancer therapy
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Home Care Services offers professional healthcare in the comfort of a patient’s home. The program
combines home recovery under the guidance of a physician with the same kind of skilled healthcare
that is available at the Cancer Institute. Services may include nursing, counseling, administering
medicines, physical and occupational therapy, and in-home personal care.

Hospice
At the University of Tennessee Medical Center, we provide hospice
services that enable terminally ill cancer patients to live more comfortably
at home during the last phase of life. The aim of the hospice program is
to give patients the best possible quality of life and to make sure they’re
comfortable. The hospice nurses and staff are there to address patients’
physical, emotional, and spiritual needs.

Social Workers
Our social workers interact with patients and families to identify
and meet their needs through counseling, support groups, help with
transportation, financial assistance, and connecting patients and families
to community resources.

Support Groups
The Cancer Institute, in conjunction with local health organizations, offers
support groups and support systems for patients undergoing treatment
and their families. In addition to face-to-face support groups, telephone
conference calls are available for the convenience of our patients.
The Cancer Institute also provides patient-to-patient mentoring programs
to help people newly diagnosed with cancer. The mentors are volunteers
and former cancer patients who are willing to talk with newly diagnosed
patients about what they’re experiencing and to connect them with useful
resources to help them through their journey.

Volunteers
A trained, dedicated group of volunteers contribute their help to the Cancer Institute and serve
as an extension of the medical center’s staff by providing a wide variety of support services.
The volunteers, many of them either former cancer patients or family members, provide music
therapy in the waiting area, help out in the chemotherapy area, bring fresh-cut flowers to brighten the
reception area, assist with wheelchairs, and provide a listening ear and helping hand to the Cancer
Institute visitors and staff.

Becky Thompson
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Author Thomas Wolfe said
you can’t go home again.

A physician born and
raised in East Tennessee
brings vast experience
in treating “women’s
cancers” to the
medical center

Larry Kilgore, MD, a board-certified
leader in gynecologic oncology, would
have to disagree. After a very impressive
and satisfying 20-year career at the
University of Alabama at Birmingham
(UAB), Kilgore is coming home to
Tennessee to spend the next stages of his
career doing what he loves best: caring for
patients and leading gynecologic oncology
services at the University of Tennessee
Medical Center Cancer Institute.
Most recently he was a gynecologic
oncologist in the Department of
Obstetrics and Gynecology at UAB, where
he focused on patient care, the delivery
of excellent service, and advanced cancer
therapies, including robotic surgery.
That was just part of his job. He also
served as a professor and held the J. Max
Austin Endowed Chair in the Division of
Gynecologic Oncology, he was a senior
scientist for the UAB Comprehensive
Cancer Center, fellowship director for
gynecologic oncology, and residency
program director in the Department
of Obstetrics and Gynecology. Kilgore
accomplished all this while publishing,
working on numerous committees and
task forces, and serving as an esteemed
board examiner for the American Board of
Obstetrics and Gynecology – affirmation
that he has the responsibility and proven
expertise to determine whether candidate
physicians possess the knowledge and
skill to receive board certification in OB/
GYN or gynecologic oncology.
Kilgore’s drive and ability were evident
at a young age. He came from humble
roots in Whitwell, Tennessee, a
small coal-mining town just outside
Chattanooga. His people were miners,
but he aspired to become a veterinarian,
somehow finding time to be active in
sports while he worked the family farm
and excelled in school. An only child,
Kilgore was encouraged to perform
well academically, and he earned many
honors, including that of being his high
school’s valedictorian. He attended the
University of Tennessee in Knoxville
and earned a BA in biology, then an MD
at the University of Tennessee Health
Science Center in Memphis. “College was
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when I decided to become a surgeon,”
he explains. “Once in medical school, I
was very interested in surgery. I went to
UAB because of its prominent fellowship
program in gynecologic oncology –
certainly one of the top three programs in
the nation.”
Although he’d planned to stay at UAB for
training and then return home, Kilgore
was offered a faculty position at the end
of his fellowship and remained there.
Now, after two decades of developing,
cultivating, and advancing his surgical
expertise and becoming a leader in
gynecologic oncology, he is inspired by
the new opportunities and challenges that
await him at the University of Tennessee
Medical Center. “I reached my career
goals at UAB,” he says. “I have a yearning
to improve the programs for treating
women with cancer at the University of
Tennessee Medical Center and in East
Tennessee. There are more people for
me to help. I love caring for patients,
advancing robotic surgery, and training
resident physicians and medical students.
There are fascinating opportunities at the
medical center.”
"We truly are blessed and honored to
have a physician of Dr. Kilgore's caliber
join our faculty and medical center," says
John L. Bell, MD, a surgical oncologist,
director of the University of Tennessee
Medical Center Cancer Institute, and
professor of the Department of Surgery
for University of Tennessee Graduate
School of Medicine. “He brings the
'entire package' with his outstanding
clinical care, proven academic skills, and
extraordinary teaching capabilities. His
'coming home' to East Tennessee will
only strengthen the Cancer Institute and
GYN oncology services to the entire East
Tennessee community. We are thankful
for his desire to be a part of our team.”
Gynecologic oncology focuses on the
diagnosis and treatment of women with
cancer of the reproductive organs, such
as ovarian, cervical, or uterine cancer.
One benefit of being treated by physicians
in this specialty is that they care for
cancer patients from start to finish, from
prevention to surgery to chemotherapy.

For Kilgore, providing gynecologic
oncology services involves offering
women in the East Tennessee region
comprehensive medical care, immediate
access to care, prevention and risk-reduction
strategies, courteous and caring support,
access to clinical trials, and advanced
treatments such as robotic surgery – all
from one source that meets the needs
of our patients and delivers truly
excellent care.
When robotic surgery was approved for
use in gynecologic oncology, Kilgore took
it upon himself to get training so that he
could offer his patients minimally invasive
surgery that results in shorter hospital
stays, quicker recoveries, less pain, and
smaller incisions. “I’m a proctor for other
surgeons and train others in robotic
surgery,” he says. “The Cancer Institute
has a need for an educator and a clinical
gynecologic oncologist with robotic
expertise, and I believe I fit that role.”
Kilgore and his wife, Patricia, have
recently become empty nesters. Their
three children are all currently in college
or graduate school: the eldest, Lauren, a
law student at Vanderbilt; Travis, in grad
school at Ohio University in Athens; and
the youngest, Joseph, in his first year at
Birmingham Southern College. Kilgore
has a passionate love of music and plays
guitar. He also enjoys running, golf, and
all UT sports.
His career achievements have made him
a nationally known physician and a
respected surgeon. For Kilgore, the decision
to choose the University of Tennessee
Medical Center signals a new era that
includes the further development of
gynecologic oncology services at the medical
center and the delivery of outstanding
care to women in East Tennessee. “This
is a call home for me,” he says. “It’s an
honor for me to bring my knowledge and
training from UAB to the medical center.
I’m ready to start my new adventure.”
Wendi Hope Hager
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Clinical Trials:

Curiosity Brings Progress

The academic medical center environment
at the UT Graduate School of Medicine and
the University of Tennessee Medical Center
brings an expectation of lifelong learning.
We never stop asking “what if,” and our patients and community
benefit from our curiosity through research results that are often
first in the nation. Our cancer clinical trials are as diverse as our
physicians and as poignant as our sense of curiosity.
Wahid Hanna, MD, a professor in the Department of Medicine
and chief of the oncology division, is the principal investigator
for many clinical trials at the University of Tennessee Medical
Center including, but not limited to, lung, blood, breast, and
prostate cancers. He also directs nationally recognized and
locally implemented research that uses PET/CT (positron
emission tomography/computed tomography) scans to show
early response to chemotherapy in patients with lung cancer.
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“What drives me to do clinical trials is the desire to make us
better,” he says. “Curiosity makes us better.”
Hanna’s PET/CT study is the first such study in the U.S.,
although similar studies have now begun elsewhere. “It’s very
promising,” he says. “PET/CT scans document the size and
activity of certain cancers. Repeating a PET/CT scan after
chemotherapy treatment gives us valuable information about
the patient’s response to cancer treatment. In our study we’re
trying to predict the suitability of cancer treatment as early as
three to four weeks, rather than waiting two to three months
in the traditional way. This could enable us to choose the best
treatment early in the course of therapy. In treating cancer, we’re
always in a race between us and the cancer. We want to, we have
to, win the race.”

What Are Clinical Trials?
In clinical trials, patients help doctors conduct important
research. Cancer clinical trials, in particular, can test treatments
for cancer, seek better ways to screen for the disease, and identify
new or improved ways of preventing it.
Clinical trials are conducted in four phases, and the trials at
the University of Tennessee Medical Center are mainly Phase II
and Phase III trials. Phase II clinical trials are conducted after a
new medication has been tested for safety and effectiveness, to
further define the extent of effectiveness and the range of dosing
that is optimal. These studies often begin comparing the new

medication to existing treatments for the same disease. These
are usually conducted in smaller number of patients. Phase
III clinical trials are carried out in larger patient populations
to determine more specific effectiveness compared to other
treatments, develop more precise dosing information, and
further understand the extent of any side effects associated
with a new medication.

Eric Carlson, DMD, MD, a professor and chair of the Department of Oral
and Maxillofacial Surgery, (seated center), and his team members Dr. Amy
LeBlanc, researcher in the Department of Radiology, Molecular Imaging
Tracer Development Program, David Gerard, PhD, a professor and director

of research in the Department of Oral and Maxillofacial Surgery, and Josh
Schaefferkoetter, BS, a graduate research assistant in Cancer Imaging, (seated
right), are working to develop a new tracer to better identify oral/head and
neck cancers using PET/CT technology.

The PET/CT study is currently in Phase II, for which 50 patients
are being recruited as participants, only at the University of
Tennessee Medical Center. And once Phase II is complete, Hanna
hopes to expand the research to cancers in the breast, colon, and
other areas of the body.
Through aggressive and focused clinical trials, Eric Carlson,
DMD, MD, a professor in and chair of the Department of Oral
and Maxillofacial Surgery, seeks to improve the prevention and
detection of head and neck cancers. Using PET/CT technology,
he’s studying the use of PET/CT imaging in staging oral and
head-and-neck cancers and working to determine whether
the activity of FDG (a radioactive tracer) in lymph nodes that
harbor cancer increases over a span of time. This research will
help identify and localize the lymph nodes that are involved
so they can be removed. He and team members Dr. Amy
LeBlanc, researcher in the Department of Radiology, Molecular
Imaging Tracer Development Program, and David Gerard, PhD,
a professor and director of research in the Department of Oral
and Maxillofacial Surgery, hope to develop a new PET/CT tracer
in the future. New tracer technology should result in more
sensitivity and greater specificity in the information obtained.
Currently, Carlson and LeBlanc are collaborating to develop.
radiopharmaceuticals that will make this process more effective.
At the University of Tennessee Medical Center we find better
ways to diagnose and treat cancer, and we don’t stop there. We
continue to develop. We continue to improve.

2009 Cancer
Clinical Trials

“Intellectual curiosity is what gives me the energy to work long
hours,” Carlson says. “It’s also one of the reasons patients benefit
by receiving care at our academic medical center. We have
clinicians working alongside basic science researchers. This brain
trust puts us ahead in translational research and patient care.”

At any given time, physicians at the
University of Tennessee Medical Center
and UT Graduate School of Medicine are

Amanda F. Johnson

Clinical trials are research studies
conducted by medical professionals in
which people help doctors identify new
or safer medical treatments for improved
quality of life. They take place only after
lengthy, detailed, and careful research
processes have been carried out, and the
trials themselves are carefully monitored
and adhere to strict guidelines.

involved in numerous studies which are
actively enrolling patients in oncology
clinical trials. Here are just a few that
originated this year:

Clinical Trial: Program for
the Assessment of Clinical Cancer
Tests (PACCT-1): Trial Assigning
Individualized Options for
Treatment: The TailorX Trial
Purpose: This study aims to help
determine which patients are most
likely to benefit from chemotherapy and
hormonal therapy following breast cancer
surgery.
Principal Investigator: Wahid Hanna,

MD, professor, Department of Medicine,
and Chief, Division of Oncology

Clinical Trial: The BeST Trial: A
Randomized Phase II Study of VEGF,
RAF kinase, and mTOR Combination
Targeted Therapy With Bevacizumab,
Sorafenib, and Temsirolimus in
Advanced Renal Cell Carcinoma
Purpose: This study is comparing four
different regimens of treatment for
metastatic renal cell cancer.
Principal Investigator: Wahid Hanna,
MD, professor, Department of Medicine,
and Chief, Division of Oncology
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Clinical Trial: A First Line
Multinational Randomized, DoubleBlind Study Comparing the Efficacy
of Afilbercept Once Every Two
Weeks Versus Placebo in Patients
to Be Treated With Gemcitabine for
Metastatic Pancreatic Cancer
Purpose: This trial is studying whether
adding the targeted drug afilbercept
to standard gemcitabine therapy will
improve survival for patients with
metastatic pancreatic cancer.
Principal Investigator: Wahid Hanna,
MD, professor, Department of Medicine,
and chief, Division of Oncology
Clinical Trial: A Double-Blind,
Randomized, Placebo-Controlled
Phase III Study to Assess the Efficacy
of recMAGE-A1 + AS14 AntigenSpecific Cancer Immunotherapeutic

as Adjuvant Therapy in Patients With
Resectable MAGE-A3 Positive NonSmall Cell Lung Cancer
Purpose: This study is examining
whether using the MAGE vaccine therapy
will be beneficial in preventing lung
cancer recurrence in patients who have
had their cancer removed and for which
the cancer expresses a particular protein.
Principal Investigator: Wahid Hanna,
MD, professor, Department of Medicine,
and chief, Division of Oncology

Clinical Trial: Phase III
Randomized Study of Radiotherapy
With Versus Without Trastuzumab
(Herceptin®) in Women With HER2Positive Ductal Carcinoma in Situ
Who Underwent Lumpectomy
Purpose: Radiation therapy is the standard
of care following lumpectomy for removal

of DCIS. This trial will look at the possible
benefit of adding trastuzumab.
Principal Investigator: Timothy Panella,
MD, chair and associate professor,
Department of Medicine
Other important clinical trials started this
year as well, including trials studying
use of a breast brachytherapy device
and research on isolated limb infusion
in patients with melanoma. Many more
are under way as well. We’re lifelong
learners, after all. If you would like to
learn about the possible clinical trial
options for yourself or a loved one, please
talk with your physician. For detailed
information about these and other clinical
trials, including eligibility requirements,
contact Barbara Munsey, manager of the
Clinical Trials Department, at bmunsey@
utmck.edu or 865-305-9773.
Amanda F. Johnson

Academic Medical Center Brings
National Experts Together
Few people would guess that for the last five years, on a cold
mid-winter Saturday, January morning, some of the nation’s
top blood cancer researchers and physicians have gathered in
Knoxville, Tennessee.
A unique continuing medical education course joins experts
from other preeminent U.S. academic medical centers with our
region’s leading cancer physicians, researchers, cancer nurses,
and technicians to discuss the latest discoveries and treatments
for blood-related diseases.
Course director Wahid Hanna, MD, UT Graduate School of
Medicine professor and University of Tennessee Medical Center
medical oncologist/hematologist, selects nationally known
experts in hematology and oncology research as teaching
faculty for the course. The faculty agree to develop original
presentations combining their areas of expertise with new
information they garner from American Society of Hematology
(ASH) national conference held every December. Each expert
then brings briefings on new treatments and discoveries to
medical professionals. Topics covered include hemostasis
and thrombosis, multiple myeloma, leukemia, and malignant
lymphoma, among others.
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“Our role in the community is education, research, and
treatment,” explains Hanna. “Part of our fulfillment of that
mission is transferring updated information from the annual
meeting. We bring national specialists in various areas of
hematology and oncology to share their expertise and up-todate information. All interested healthcare professionals are
invited to attend. It’s extremely informative and applicable to
clinical practice.”
This year’s course, the Sixth Annual Hematology Conference, is
set for Saturday, January 23, 2010, at the UT Conference Center.
Selected faculty include
• Thomas Habermann, MD, Mayo Clinic
• Michael Keating, MB, BS, MD Anderson Cancer Center
• Craig Kessler, MD, Georgetown University

On the Road to
Better Health
Out of Our Office and Into Yours
While the lifesaving patient care provided inside the walls of
the University of Tennessee Medical Center Cancer Institute
is second to none, work occurring outside those walls is also
saving lives. When medical staff and employees of the Cancer
Institute are “out of office,” it’s most likely because they’re out in
the community presenting important messages about prevention
and early detection. Education is a key component in the Cancer
Institute’s mission of providing the highest level of patient care.
And that care begins long before people reach the medical center.
For many, it begins “out of office” – in the communities where
they live, the businesses and industries where they work, and the
places where they worship.
Improving breast-health knowledge and helping people
recognize the importance of routine cancer screening is a central
goal of the Cancer Institute’s Breast Health Outreach Program
(BHOP). Founded in 1996, this successful endeavor began as
a pilot project in two rural East Tennessee counties, educating
women about breast health and offering convenient access to
on-site screening in the medical center’s mobile mammography
unit. BHOP now provides screening and educational classes
across the medical center’s 21-county service area, through
businesses, community centers, churches, and housing
authorities. BHOP has become a model for other programs
around the country.

• Sagar Lonial, MD, Emory University School of Medicine
For more information about this important educational program,
contact us at 865-305-9190.
Lea Anne Law
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Barbara Munsey checks for skin cancer at the
community SunScreeners program.

The latest program taking the Cancer Institute staff and
physicians into the community is a pilot gastrointestinal
outreach program that educates participants about colorectal
cancer and the importance of the colonoscopy screening.
“Because colon polyps can often be detected and removed
before becoming cancerous, we must provide education for
both the general public and clinical professionals about
warning signs and the importance of early detection,” says
Keith Gray, MD, a surgical oncologist with the Cancer Institute.
The pilot program has been successful in promoting this
important screening and will be expanded to more locations
in the coming years.

“We’re proud of the work BHOP has done to change attitudes
and behavior regarding breast cancer,” Cancer Institute director
John L. Bell, MD, says. “Thanks to the education and screenings
provided, breast cancers are being diagnosed that might have
otherwise gone undetected.”
And it’s not only breast cancer that the Cancer Institute’s
community outreach is helping to track down. Other equally
important Cancer Institute initiatives have emerged, based on
the successful BHOP model. During prostate-cancer awareness
month each September, hundreds of men across the region
receive free screenings for the disease. “Because one in six men
will develop prostate cancer in their lifetime, we understand
the vital need to provide easily accessible screenings,” says
Georgette Samaras, education coordinator at the Cancer
Institute. The screenings include a blood test for prostatespecific antigen (PSA) and a digital rectal exam performed by
a medical center urologist. The response to the program has
been extremely positive and new sites across the region have
been added annually to meet the increased demand and provide
access for people with the most need. Excluding skin cancer,
prostate cancer is the most frequently diagnosed cancer in men,
and early detection is the key to survival.
Skin cancer, however, should never be overlooked where risk
reduction, screening, and early detection are concerned. It is the
most common form of cancer in the United States for both men
and women, yet often there’s too little awareness of it. While
the incidence rates for many other types of cancer are leveling
off, those for skin cancer and melanoma continue to rise.
Understanding that more needs to be done to inform the public
about the lifesaving benefits of skin-cancer screening, the

Peggy Iachetta

Cancer Institute established its SunScreeners program. James
Lewis, MD, a surgical oncologist specializing in melanoma at
the Cancer Institute, says,

“The best way to avoid this potentially
deadly disease is to limit your exposure
to the sun. The SunScreeners program
detects skin cancers early and
ultimately saves lives.”
The Cancer Institute has been spreading the word about
skin cancer in a variety of ways. It shares information on the
importance of wearing sunscreen and provides special software
to visually show people what they will look like after years
of exposure to harmful ultraviolet rays. Participants learn
about warning signs and are offered free skin screenings that
use special lighting to detect skin cancers. The SunScreeners
program has been offered in workplaces, at senior centers, and
at outdoor sporting events. A number of people have been
referred to dermatologists for further evaluation, and several
cases of melanoma have been detected in early stages as a result
of the free screenings.

The medical center‘s digital mobile
mammography unit is on the road
six days a week and will provide
over 3,800 mammograms to East
Tennessee women in 2009.
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Because prevention is crucial in the war against cancer, the
Cancer Institute continues to provide a free eight-week
smoking-cessation program and a quarterly educational lecture
series that’s open to the community. The ultimate goal of all
these initiatives is to decrease the burden of cancer across
East Tennessee through education and screening. So whether
the concern is breast health, sun safety, or prostate cancer,
the important message of prevention and early detection is
spreading – thanks to the “out of office” professionals at the
University of Tennessee Medical Center Cancer Institute.

Reeling in a Healthier Life
How SunScreeners Helped Make it Happen
Curtis Moore, divisional director of Oak Ridge National Laboratory’s
Campus Support and Instrumental Division, is thankful for the
SunScreeners program at the University of Tennessee Medical Center
Cancer Institute.
As far as Moore is concerned, the SunScreeners program saved his
life. “I had a spot on my arm for about five to six years,” he says. “My
daughter told me I needed to get it checked out, and I thought I might
as well, since it was free and on campus.
Because of my results from the SunScreeners program, it was
recommended that I follow up with a dermatologist due to suspicious
findings, so I did. A biopsy was performed, and I was diagnosed
with lentigo maligna, a type of malignant melanoma, also known as
Hutchinson’s freckle. Two weeks later I had it surgically removed.
My dermatologist told me I was lucky that it didn’t spread down into
my lymph nodes, requiring further treatment.
If it wasn’t for the SunScreeners program, I probably wouldn’t have
gone to get it checked out. Now I tell my staff, ‘Get it checked out. It
saved my life, and it could save yours’.”
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OPPORTUNITIES | News from the University of Tennessee Medical Center and UT Graduate School of Medicine Development Office

“ The Avon

Foundation for Women is proud

to support the University of Tennessee Medical Center through
the Safety Net program, which supports more than 100 organizations
across the U.S. Together, these organizations provide lifesaving care
for uninsured, low-income, and underserved women and men
who otherwise might not be able to overcome
those obstacles and access the services.”
Marc Hurlbert, PhD Director, Avon Foundation Breast Cancer Crusade

PHILANTHROPY PLAYS KEY ROLE IN SUCCESS OF HEALTHCARE OUTREACH

Since 1996, the University

of Tennessee Medical Center’s Breast
Health Outreach Program has reached
more than 20,000 women throughout
East Tennessee. In addition to sharing
information about the importance
of early detection of breast cancer
and referring significant numbers of
women for mammograms and clinical
breast exams, the program operates
a mammography unit that provides
screening mammograms to more than
3,800 women annually, including
those in rural areas, who often have
limited access to preventive care.

According to Mae King, director of the
Breast Health Outreach Program (BHOP),
“The reason we exist, the reason we’re able
to reach so many women and provide
them with state-of-the-art preventive
care, is because of philanthropy from
both individuals and organizations like
the Avon Foundation for Women.”
For eight years the Avon Foundation
has supported BHOP through grants
which provide funding for education
programs which increase awareness of
the lifesaving benefits of early detection.
This past year the medical center
24 | Frontiers

received an additional $358,000 to
complete the conversion to an all-digital
mammography system in our mobile
mammography unit. This new equipment
allows for easier and more comfortable
screenings for patients. Other benefits
include lower X-ray radiation dosage
and the direct conversion of X-rays into
digital images. Because the technologist
can view images immediately, image
quality can be confirmed on the spot,
eliminating the need for technical recalls.”
Here is an interview with
Marc Hurlbert, PhD,
director of the Avon Foundation
Breast Cancer Crusade:
UTMC: In general, how would you
characterize the role of philanthropy
in addressing education, treatment,
and awareness of women’s health
issues, particularly breast health?
Hurlbert: Philanthropy plays a unique
and essential role in advancing breast
health awareness and education. Many
of the most vulnerable populations aren’t
reached by top-line information on the
importance of early detection of breast
cancer. Philanthropic organizations,

especially at the grassroots level, are
in a trusted position. They’re able to
reach the hard-to-reach and medically
underserved populations with culturally
effective messaging and, in the case of
Avon Foundation-funded programs, to
provide a link to high-quality, accessible
screening services. These organizations
fill a vital gap in raising awareness
and providing education and services
to millions of women and men who
otherwise might not be able to access this
information or the healthcare system.
UTMC: How are healthcare organizations
across the country using funds and
grants from the Avon Foundation
to advance their mission and the
mission of the foundation?
Hurlbert: The Avon Foundation for
Women was founded in 1955 to improve
the lives of women, and it brings this
mission to life through a focus on two
key issues, breast cancer and domestic
violence. The Avon Breast Cancer
Crusade launched in 1992, and Avon
breast cancer programs in some 50
countries have raised more than $585
million to advance access to care and
help find a cure for breast cancer, with

a focus on medically underserved
populations. Funding is awarded to
beneficiaries ranging from leading cancer
centers to community-based breast
health programs, to support five critical
areas: awareness and education, screening
and diagnosis, access to treatment,
support services, and scientific research.
UTMC: The Avon Foundation and
UTMC’s Breast Health Outreach
Program have been partners in this
mission for quite some time. Can
you elaborate on that relationship
and on how the two have worked
to fulfill this greater mission?
Hurlbert: The University of Tennessee
Medical Center’s Breast Health Outreach
Program began delivering breast health
education and mobile mammography
services in 1996 to women living in
two remote and rural East Tennessee
counties. Now operations have expanded
to serve 21 counties and reach 3,800
women annually. The Avon Foundation
for Women has been a supporter of
the Breast Health Outreach Program
through the Avon Foundation Breast
Care Fund, which supports organizations
providing education and outreach to
medically underserved communities.
We have witnessed UTMC’s solid track
record of success in reaching a very
rural and hard-to-reach population.
The recent grant to upgrade from
film to digital mammography on the
mobile van allows UTMC to further

expand its mammography screening
in the rural community and provide
access to better image quality and
earlier detection of cancers for this
medically underserved population.
UTMC: What impact have you seen as
a result of the grants awarded across
the country by the Avon Foundation?
Hurlbert: Fortunately, there are so many
highlights to share. To name just a
few regarding access to care and
screening programs in 2008:
A million women received breast
health education through the
efforts of outreach workers at
145 community-based grassroots
organizations that reach all 50 states.
150,000 women were given
the opportunity to receive a
mammography screening.
UTMC: What can others do to play
in a role in breast cancer awareness,
outreach, and prevention?
Hurlbert: The efforts of the Avon
Foundation for Women are only possible
because of the philanthropy of others.
The foundation raises the money it grants
out on a year-to-year basis through the
sale of a variety of “pink ribbon” products
and through events, races, and walks; the
largest is the U.S. Avon Walk for Breast
Cancer series. Being involved, whether
through the donation of time or resources,
is key to the success of this mission.

The Breast Health Outreach Program,
a service of the Cancer Institute at the University
of Tennessee Medical Center, reaches out to
provide breast health education and low-cost
and free mammograms to thousands of women
throughout the East Tennessee region. The
program is made possible by the philanthropic
generosity of granting organizations like Avon
Foundation for Women, Susan G. Komen for
the Cure, and Champions for a Cure, as well as
hundreds of individual supporters.
Here are just a few examples of how those
philanthropic dollars have affected East
Tennesseans through the Breast Health
Outreach Program (BHOP):
Free education classes have taught women about
the warning signs of breast cancer, the benefits
of early detection, and the importance of breast
self-exams, clinical breast exams, and screening
mammograms. Through the education classes
and screening mammograms provided by the
mobile mammography unit, BHOP has reached
over 20,000 women throughout East Tennessee.
Participants who get screening mammograms
from the mobile mammography unit and need
further diagnostic exams receive comprehensive
care through the UT Breast Care Service. Nurse
“patient navigators” provide a central point of
contact to help ease worries and assist women
through the follow-up process.
BHOP provided access to mobile mammography
services for almost 3,800 women in 2008 and
provided 603 free mammograms to uninsured
women across the region through grant funds.
Seven breast cancers that might otherwise
have gone undetected were diagnosed through
BHOP in 2008. A recent note from a grateful
community member shows the importance of
these services:
“Thanks to BHOP, our secretary (who is only
41 years old) scheduled a mammogram because
of the convenience. She was diagnosed with
Stage III breast cancer and as a result had a
double mastectomy. Her oncologist told her that
if it had been just one year later, there would
have been nothing he could have done for her.
We are extremely grateful for UT’s BHOP.”
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For more information about these stories or other philanthropic opportunities at the University of Tennessee Medical Center or UT Graduate School of Medicine
please contact the Development Office, 865-305-6611 or development@utmck.edu

The Regal Foundation

THE TORCH CAMPAIGN

is an annual fund-raising campaign for employees
of the University of Tennessee Medical Center
and UT Graduate School of Medicine that unites
our employee family in philanthropic support of
programs affecting patient care, education, and
research. This important effort, conducted in a
spirit of compassion and kindness, raised more
than $240,000 in 2009 for programs like the Heart
Hospital, the NICU, the UT Graduate School of
Medicine Dean’s Education and Research Fund,
and the Preston Medical Library.
Thank you to all of the 3,400 employees who participated in the Torch
Campaign, for your unwavering commitment and generosity toward the
patients and families we serve throughout East Tennessee.

SMOKY MOUNTAIN KNIFE WORKS CORPORATE TEAM

THE MAN RUN
With one in six men diagnosed with prostate

Regal Foundation and Will Rogers Institute
Partner with University of Tennessee Medical Center

to advance Pulmonary

Care

N

ever an organization to shy
away from supporting and
strengthening the communities it
works in, the Regal Foundation,
the charitable arm of Regal Entertainment
Group, has taken action in East Tennessee
(as well as elsewhere) to address some
of the most important health issues
affecting the area’s people. With the Will
Rogers Institute, the foundation recently
donated $1 million to the University of
Tennessee Medical Center for the purpose
of establishing the Mike Campbell
Pulmonary Medicine Fellowship.
“Regal Entertainment Group has a culture
of giving back to the communities in
which we live and operate,” says Amy
Miles, the company’s CEO and a UT
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alumna. “This philanthropic attitude has
always been a priority of our executive
chairman, Mike Campbell. So it’s very
well deserved and appropriate that
our gift to Medical Center be directed
toward establishing a pulmonary
fellowship in Mike’s name.”
Regal knows that such a gift has a
multiplier effect. Besides fostering
enhanced research and training for
physicians specializing in pulmonary
disease, the fellowship will attract the
nation’s leading pulmonary residents
and ensure that East Tennesseans,
who have a disproportionate share of

Mike Campbell
Executive Chairman

chronic lung diseases and ailments,
continue to get access to the latest
in pulmonary treatments. Bringing
these doctors into the community
means better care and a higher quality
of life for people who live here.
“It’s this type of philanthropic mind-set
and commitment that will have a real
impact for community members suffering
from pulmonary ailments ranging from
asthma to chronic lung disease,” says
Teresa Levey, vice president of the medical
center’s Heart Lung Vascular Institute.
“Regardless of the size of the gift,
philanthropy truly makes a difference.”

cancer during their lifetime, this type of cancer is the most
common found in men except for skin cancers. To help
fight it, hundreds of community supporters, prostate
cancer survivors and their families, and physicians and
other staff from the University of Tennessee Medical Center
met on August 29 at the medical center to participate in
the second annual MAN RUN, presented by SunTrust
Bank of East Tennessee. This 5K race on a new certified
course, along with a one-mile fun walk, honors prostate
cancer survivors and increases awareness of the disease.
It also raises funds that provide free prostate-cancer
screenings and outreach programs throughout the
community, delivered by the University of Tennessee
Medical Center Cancer Institute.

This year’s event raised more than $21,000 and has helped
provide screenings for 500 men throughout East Tennessee.
More than 625 runners came together in this important
effort to show their support for men and families affected
by prostate cancer. “THE MAN RUN is an excellent
opportunity for families to come together, have a good
time, and support prostate cancer screening, education, and
outreach programs in the Knoxville area,” said Fred Klein,
MD, a University of Tennessee Medical Center urologist.
“Last year we created THE MAN RUN to serve as the
region’s first community-wide event to recognize prostate
cancer as a significant health issue, promote early detection
of prostate cancer through screening and awareness, and
celebrate prostate cancer survivors.”
About 192,000 men will be diagnosed with prostate
cancer in 2009, according to the American Cancer Society.
More than 27,000 men died of the disease last year. Early
detection by means of prostate cancer screenings and
other methods is crucial to boosting the survival rates.

Lights ofLove

The University of Tennessee Medical Center Pastoral Care program is
pleased to announce the second annual Lights of Love.
Lights of Love is a year-round program providing a special way to honor
or remember a loved one, to recognize a holiday or other special event,
or to say thank you for medical care received. All donations support the
Pastoral Care program and its important work of providing emotional and
spiritual guidance to medical center patients, families, and staff.
We invite you to participate by giving a light to be placed on the Lights
of Love trees located throughout the medical center’s Healing Garden.
You can give a light for a minimum donation of $15. Names of honorees
and those giving in their names will be listed in the Lights of Love
Remembrance Book at www.utmedicalcenter.org.
To contribute to Lights of Love, please contact the Office of Development
at 865-305-6611 or development@utmck.edu. Or you may complete the
online form at www.utmedicalcenter.org.

Continuing in the tradition of success and elegance, the University of
Tennessee Medical Center and UT Graduate School of Medicine are honored
to announce the next An Evening in Orange gala, to be held Saturday,
January 16, 2010, at Knoxville’s Cherokee Country Club. Under the
leadership of event co-chairs Christy and Teddy Phillips and the An Evening
in Orange committee, the upcoming An Evening in Orange will expand its
legacy as Knoxville’s premier fund-raising event.
Proceeds from the gala will benefit the new Heart Hospital scheduled for
completion in 2010. The new Heart Hospital will allow the University of
Tennessee Medical Center to advance a new standard of care for patients
with cardiac, pulmonary and vascular diseases while continuing to reinforce
our mission of serving through caring, education and discovery. As East
Tennessee’s first integrated center dedicated to the prevention, detection, and
treatment of these disorders, patients will experience seamless, coordinated,
patient-centric care, and follow-up in one central location.
We extend our sincere gratitude and appreciation to our sponsors for
joining us in this important event. Their partnership has helped us to create
a state-of-the-art facility offering healing and medical advancements to
individuals throughout the East Tennessee region who face the challenges of
cardiovascular, pulmonary, and vascular ailments.
For further information regarding An Evening in Orange, please contact the
Office of Development at 865-305-6611 or development@utmck.edu.
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David “Ken” Wilson

Winter 2009-2010

CME Course Calendar
“I’d like to thank my doctors at UT
and their staff for the excellent care
they have given me, and the folks
at the Cancer Center who have
given me the opportunity to get
my message out to groups about
prostate cancer.”

If you are a physician, researcher, allied health professional, or
faculty member seeking continuing medical or dental education,
you might be interested in these upcoming programs offered by
UT Graduate School of Medicine.

December 8 Up to 1 AMA and AAPA credit or .1 CEU will be available per session.
Department of Internal Medicine Grand Rounds: Cardiac Device
Infections
7 a.m. to 8 a.m., Morrison’s Conference Center, University of Tennessee Medical Center,
Knoxville, Tennessee

January 11 Up to 1 AMA and AAPA credit or .1 CEU will be available per session.
Neurology/Neurosurgery Quarterly Case Conference: Stroke
Jointly sponsored by the Brain and Spine Institute and UT Graduate School of Medicine
7 a.m. to 8 a.m., Morrison’s Conference Center, University of Tennessee Medical Center,
Knoxville, Tennessee

January 12 Up to 1 AMA and AAPA credit or .1 CEU will be available per session.
Department of Internal Medicine Grand Rounds: Androgen Therapy
in Men and Women
7 a.m. to 8 a.m., Morrison’s Conference Center, University of Tennessee Medical Center,
Knoxville, Tennessee

It’
s a role he never saw himself
in – at least not before he heard the
words “You have cancer.” But since being
diagnosed with Stage IV prostate cancer
and given four years to live, David
“Ken” Wilson has become a committed
spokesperson and advocate for prostatecancer education and awareness, as well
as a confidant, motivator, and friend to
many men diagnosed with the disease.
“I was so angry for a while,” he says, “but
I finally realized that wasn’t doing me
or anyone else any good. So I decided
to use my 30 years of sales experience
to talk to anyone who would listen. ‘My
story doesn’t have to be your story,’ is
what I tell them. ‘This disease doesn’t
have to kill you.’”
Wilson spends a great deal of his time
talking to men one-on-one and speaking
to church, civic, and business groups.
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His message is simple: “Early detection,
early cure – late detection, long hard
cure and sometimes no cure at all.”
“I use my story to encourage them,” says
Wilson. There are many misperceptions
out there that he says need to be cleared
up. “Most people think prostate cancer
is slow-growing and that going for a
screening once every few years is enough.
I’m here to tell you that that’s not the
case. You can’t count on having one of
the slow-growing types.”
Recently Wilson served as chair of the
second annual Man Run. The event
drew 625 participants. The Man Run is a
fund-raiser to recognize prostate-cancer
survivors, increase awareness about
prostate cancer, and raise dollars for free
screenings. “As a result of the Man Run,
we screened approximately 500 men in
the month of September alone,” Wilson

says. “I guarantee you, these screenings
will save someone’s life.”
For men who have been diagnosed with
prostate cancer, Wilson participates in
Man-to-Man, a men’s prostate-cancer
support group at the University of
Tennessee Medical Center. This forum
provides a place where men can talk
to one another about many of the
issues they are facing as a result of their
diagnosis. Wilson attends the monthly
meeting to support and motivate other
survivors in the fight against prostate
cancer.
He is often asked how he gets through
each day, knowing the seriousness of
his health problem. His answer is, “The
unconditional love of my Lord and Savior
Jesus Christ and the unconditional love
of Frieda, my wife of 50 years.”

UT Earns Top-Level CME Accreditation
UT Graduate School of Medicine’s exemplary efforts in meeting new
methods for planning and evaluating continuing medical education
(CME) have helped UT College of Medicine earn Accreditation with
Commendation from the Accreditation Council for Continuing Medical
Education (ACCME). Jointly, the College of Medicine campuses in
Knoxville, Chattanooga and Memphis earned the top-level accreditation
during the statewide four-year reaccreditation review.
“Accreditation with Commendation is awarded to providers [who]
demonstrate compliance in all 22 criteria,” said Murray Kopelow, MD,
Chief Executive, ACCME, in a letter. “The ACCME…commends your
organization for not only meeting ACCME’s accreditation requirements…
but for demonstrating that yours is a learning organization and a
change agent for the physicians you serve. You have demonstrated an
engagement with your environment in support of physician learning and
change that is part of a system for quality improvement.”
The ACCME is the accrediting body for CME providers offering
physicians continuing education credits from the American Medical
Association. To reach the level of Accreditation with Commendation,
the UT offices met or exceeded all ACCME criteria for purpose, mission,
educational planning, evaluation, improvement, and engagement.
“This is the highest accreditation possible for CME providers,” says
James Neutens, PhD, dean of UT Graduate School of Medicine. “It
demonstrates our staff’s dedication to excellence, understanding of the
intricate ACCME regulations, and desire to conduct business ethically
and professionally.”
The reaccreditation process for providers with Accreditation with
Commendation is extended from four years to every six years. If you
have questions about continuing medical education activities, contact
Communications and Outreach at 865-305-9190 or CME@utmck.edu.

January 23 Up to 5 AMA and AAPA credits or .5 CEU will be available.
Sixth Annual Hematology Conference: An Update on Selected ASH Topics
The sixth annual Hematology Conference: An Update on Selected ASH Topics provides an update on recent advances in
the treatment of blood cancers, including a review of the biology of specific types and an update on recent clinical trials.
Participants learn about new data and treatment strategies aimed at improving patient outcomes and quality of life. The
topics include hemostasis/thrombosis, chronic lymphocytic leukemia, multiple myeloma, and malignant lymphoma.
Nationally acclaimed experts in their fields will lead discussions, including Thomas Habermann, MD, Mayo Clinic; Michael
Keating, MB, BS, MD Anderson Cancer Center; Craig Kessler, MD, Georgetown University; and Sagar Lonial, MD, Emory
University School of Medicine.

The University of Tennessee Graduate School of Medicine
Presents

Sixth Annual Hematology
Conference: An Update on
Selected ASH Topics
Saturday, January 23, 2010
UT Conference Center
Knoxville, Tennessee
Featuring
Thomas Habermann, M.D.
Professor of Medicine
Mayo Clinic
Michael Keating, M.B., B.S.
Professor of Medicine
MD Anderson Cancer Center
Craig Kessler, M.D.
Professor of Medicine
Georgetown University
Sagar Lonial, M.D.
Associate Professor of
Hematology and Medical Oncology
Emory University School of Medicine
A Continuing Medical Education activity planned, managed
and certified for CME by the University of Tennessee Graduate
School of Medicine and the UT College of Medicine.

Space is limited.
Register today!
More information at www.tennessee.edu/cme/Hematology2010

March 13
Sixth Annual Diabetes Regional Conference: Evidence-Based Interventions to Stem the Burden of Diabetes Complications
UT Conference Center, Knoxville, Tennessee
The costs, morbidity and mortality from diabetes are severe, but the numerous complications and associated risk factors account for the overwhelming
burden of the disease. The Sixth Annual Diabetes Regional Conference will help physicians stem these health consequences by learning and applying the
most recent evidence-based treatment strategies and interventions to improve health outcomes and quality of life for patients.

To register or for more information about these courses,
call 865-305-9190 or visit our website
at www.tennessee.edu/cme.

